drugset / Trial / NCT00929578

Fluphenazine Hydrochloride for Psoriasis

NCT00929578

Phase 2 Completed 15 enrolled Tufts Medical Center Immune Control · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to assess the safety and biologic activity of intralesional injection of fluphenazine in adult subjects with psoriasis.

Timeline

Start
2008-11
Primary completion
2010-11
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluphenazine Small molecule 100 ug/ml Other
Comparator Fluphenazine Small molecule 500 ug/ml Other
Comparator Fluphenazine Small molecule 2500 ug/ml Other

Indications